We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cardiac Arrest Deaths Cut 50% by Emergency Team

By HospiMedica staff writers
Posted on 25 Feb 2002
A study has found that early intervention by a hospital emergency team can slash the number of deaths from unexpected cardiac arrest by 50%. More...
The study was conducted by a team of Australian researchers, led by Michael D. Buist, M.D., director of the intensive care unit (ICU) at Dandenong Hospital (Dandenong, VIC).

The researchers recorded the level of cardiac arrests and the deaths that resulted in a single hospital in a year before (1996) and after (1999) the introduction of a medical emergency team. In 1996, 73 cases of unexpected cardiac arrest occurred, compared with only 47 in 1999. Similarly, death rates were reduced form 77% in 1996 to 55% in 1999, when the emergency team was in place. Overall, the intervention was associated with a 50% reduction in cardiac arrest. The study was reported in the February 16, 2002, issue of the British Medical Journal (BMJ).

The emergency team was proposed as a pre-emptive response system to manage patients with signs of clinical instability, such as deterioration in the airway, circulation, or respiratory system for at least one hour before their index event. When clinical observations reach certain predefined critical limits, the primary care nurse or medical officer calls for the emergency team, which responds immediately. The team comprises a medical registrar, an intensive care registrar, and a senior intensive care nurse. The team is equipped with resuscitational drugs, fluids, and appropriate equipment.

The specific criteria for calling the emergency team were respiratory distress or threatened airway; breathing problems (respiratory rate over 30/min or less than 6/min, SaO2 less than 90% when on oxygen, or difficulty speaking); circulation problems (blood pressure over 90 mm despite treatment or pulse rate over 130/min); and neurologic problems (decrease in consciousness, agitation or delirium, or seizures). Additional criteria included concern about the patient, uncontrolled pain, failure to respond to treatment, and inability to obtain prompt assistance.



Related Links:
British Medical Journal

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.